Treatment with essential metalloelement (Cu, Fe, Mn, and Zn) chelates or combinations of them before and/or after radiation injury is a useful approach to overcoming radiation injury. No other agents are known to increase survival when they are used to treat after irradiation, in a radiorecovery treatment paradigm. These chelates may be useful in facilitating de novo syntheses of essential metalloelement-dependent enzymes required to repair radiation injury. Reports of radioprotection, which involves treatment before irradiation, with calcium-.channel blockers, acyl Melatonin homologs, and substituted anilines, which may serve as chelating agents after biochemical modification in vivo, as well as Curcumin, which is a chelating agent, have been included in this review. These inclusions are intended to suggest additional approaches to combination treatments that may be useful in facilitating radiation recovery. These approaches to radioprotection and radiorecovery offer promise in facilitating recovery from radiation-induced injury experienced by patients undergoing radiotherapy for neoplastic disease and by individuals who experience environmental, occupational, or accidental exposure to ultraviolet, x-ray, or ,-ray radiation. Since there are no existing treatments of radiation-injury intended to facilitate tissue repair, studies of essential metalloelement chelates and combinations of them, as well as combinations of them with existing organic radioprotectants, seem worthwhile.
Ingested foods and beverages contain these essential metalloelements in chelated forms, which may yield other chelates as a result of ligand exchange in the digest or following absorption [4] . However, some of the absorbed chelates may exist in the digest and in blood as the original chelate or a more stable ternary chelate. Absorbed metalloelement chelates undergo systemic circulation to all tissues and utilization by all cells following ligand exchange with small molecular mass ligands, apoproteins, and apoenzymes to form metalloproteins and metalloenzymes in de novo syntheses. These metalloelements are stored in the appropriate tissues as MTs or Fe-Ferritin, or they are excreted in the event tissue needs have been met and stores replenished [4] . There are no inducible excessive storage diseases known in normal individuals. Hovever, there must be upper limits dictated by physiological requirements.
Stored essential metalloelements are released as chelates via ligand exchange to meet normal metabolic needs. This homeostatic release of relatively small amounts of essential metalloelement chelates meets normal physiologic requirements. Release of larger quantifies in a pronounced mobilization of these metalloelements is a feature of interleukin-1 (IL-1) and other cytokine mediated acute and chronic responses to many disease states [4 and cited refs] .
It is likely that the magnitude of these responses is adequate in normal well-nourished individuals and allows them to overcome their disease. However, it is now generally recognized that dietary intakes of Cu, Fe, Zn [37, 38] , and most likely Mn are less than recommended daily intakes for the U.S. population and may be no better for individuals living in other developed countries. Individuals who have depleted stores of these essential metalloelements, such as chronic disease patients, may overcome pathology associated with their disease state, which always involves inflammation, more slowly or not at all. The degree of radiation injury and the nutritional state of health of an individual may determine whether or not an individual will be able to overcome metalloelement-dependent repairable radiation injury. Treatment with essential metalloelement chelates either before and/or after radiation injury may support these essential metalloelement-dependent responses or facilitate recovery regardless of the state of nutriture.
Chemical Consequences of Ionizing Radiation
Since water represents 70% of the chemical composition of the adult body (90% of the infant body), its chemical transformation by ionizing radiation merits serious consideration with regard to chemical consequences of ionizing radiation. Ionizing radiolysis of water is well understood and produces very. reactive aquated electrons, monoatomic hydrogen atoms, hydroxyl radical, hydrogen peroxide, and protonated water as well as superoxide (O2-) and hydroperoxyl radical in the presence of oxygen. Hydroperoxyl radical, hydroxyl radical, monoatomic hydrogen, and aquated electrons have very short half-lives of the order of milliseconds and consequently react rapidly with cellular components in reduction, oxidation, initiation, insertion, propagation, and addition reactions causing loss of function and the need for biochemical replacement and/or repair. Ionizing radiation can also impart sufficient energy to all biochemicals to cause homolyltic bond breaking and produce all conceivable organic radicals in considering C-C, C-N, C-O, C-H, P-O, S-O, etcetera bond homolyses. These radicals will undergo the above listed radical reactions to cause further destruction and the need for replacement and/or repair. A third consequence of ionizing radiation is homolytic or heterolytic bond breaking of coordinate-covalent bonded metalloelements. These are the weakest bonds in biochemical molecules and potential sites of greatest damage, which may be most in need of replacement and/or repair since many repair enzymes are metalloelement-dependent.
Recognizing that loss of essential metalloelement-dependent enzyme activity may at least partially account for lethality of ionizing radiation and that Cu-, Fe-, Mn-, and Zn-dependent enzy.mes have roles in protecting against accumulation of O-as well as facilitating repair [39] Oxidase which does synthesize 02-has been recently demonstrated in the liver of 3 to 9 Gray (Gy) irradiated mice [40] . More reactive oxygen-radicals derived from 02-include: singlet oxygen and hydrogen peroxide, produced as a result of acid-dependent self disproportionation or water-catalyzed dispt)portionation of O_-.
hydrox3'l radical, and hydroperoxyl radical [41, 42] . Facilitated de now syntheses of Cu_Zn_,SODs and catalase and decreasing or preventing formation of these oxygen-radicals may account for some of the recovery from pathological changes associated with irradiation, which cause systemic inflammatory disease and immunoincompetency in the case of whole-body irradiation, and focal inflammatory., disease associated with local irradiation.
Radiation-Induced Tissue Injury Ionizing radiation is known to cause a variety of tissue injuries at all levels of biochemical systems. Acutely toxic radiation syndromes are well known in terms of doses of radiation and clinical courses of these syndromes [43] . Doses of radiation that are less than those that cause death in the short term as well as ultraviolet irradiation cause a variety of disease states depending upon the biochemical injury of the affected tissues. Consequences of ionizing and ultraviolet irradiation are a matter of current concern. Radiation risk of fatal malignancy associated with commonly performed coronary angiography was found to be around in 6,000 with a risk of fatal lung cancer of about in 8,000, an increase of 0.017% above the normal incidence for the general population [44] . Longer and more complicated procedures carry a greater risk consistent with the well known phenomenon of radiation-induced carcinogenesis [45] . Radiation-Induced skin injury, is also an unwanted consequence of this procedure and more so for all ex vivo irradiations of neoplastic tumors [44] .
Adult CF male rats x-irradiated with 0.015 centiGy see 1 day 1 for 7 days followed by 7 days rest for either 3 months or 6 months showed duration related patchy skin hyalinization, which became completely hyalinized during the succeeding 6 months without irradiation [46] . The concentration of Zn in skin of these rats remained normal in both irradiated groups but by the end of yr it had significantly (P < 0.001) decreased to [46] . Recent studies of pregnant women who resided in a heavily exposed area of the Republic of Belarus following the Chemobyl catastrophe appear to be at risk for development of toxemia, renal insufficiency, and anemia. Neonates born in heavily contaminated areas were found to be at risk for development of anemia, congemtal malformations, and perinatal death. Decreased concentrations of erythrocyte Cu and Zn were documented for these neonates. Diminished white blood cell, T-helper cell, and T4 cell counts were found for neonates from areas of heavy exposure [47] .
Radiation Protection and Recovery with Copper Chelates.
Small non-toxic doses of Cu(II)2(3,5-DIPS)4 ranging form 5 to 80 amol kg -of body mass increased survival of lethally irradiated mice treated orally or subcutaneously (sc) before irradiation, while smaller doses ranging down to 2.5 rnol Cu(II)2(3,5-DIPS)4 kg given sc 3 hr after irradiation, the radiation recover?.." paradigm, also increased survival [48 and cited refs.] . In a recent radiorecovery study, doses of 5, 10, or 20, lamol Cu(II)2(3,5-DIPS)4 kg "1 given 3 hr after LDs0/0 (8 Gy, 1.4 Gy min"1) irradiation produced sua'vivals of 52%, 606, or 52%, increases of 63%, 88% (P < 0.05), or 63%, respectively, compared to vehicle-treated control mice, and also facilitated recovery of radiation-reduced loss of body mass (P < 0.05) and recovery of radiation-induced loss of physical activity (locomotion) (P < 0.001) [49] . Radiorecovery and/or radioprotectant activity of Cu-containing compounds or complexes should be recognized as possibly facilitating activation of Cu-dependent proteins and enzymes required for repair of radiation injury, including induction of metallothioneine (MT) synthesis, and recovery of radiation-induced immuno-incompetency. In this context, cytokines such as interleukm-1 OL-1), tumor necrosis factor, stem cell factor, and interleukin-12 have recently been suggested to restore function to tissues damaged by irradiation and protect mice from radiation lethality when given before irradiation [53] . In contrast, cytokines such as transforming growth factor I, interleukin-6, and interferon, given before irradiation, sensitize mice and increase radiation lethali.ty [54] . It is most likely that there are complex cytokine interactions relevant to the amount of cytokine nthesized and timing of release in responding to the degree of radiation injury.
Additional evidence for this comes from the correlation between survival of irradiated keratinocytes and the synthesis of IL-6 [55] . It is also known that changes in ceruloplasmin (Cp), a Cu-dependent multifunctional plasma enzyme, the plasma Zn containing a2-macroglobulin, and transferrin, the plasma Fe transporter, mediated responses to injury are regulated by IL-1 and other cytokines m facilitating tissue repair processes. Addition of inflammatory cytokines; IL-lt, IL-II or inorganic Cu to hepatocyte culture medium increased mRNA Ibr MT-I, MT-2, and Cp in a coordinated cytokine-activation of hepatic cells as an acute phase response to inflammation [56] . These observations offer a clearer understanding of the well-known cytokine-mediated acute phase response to inflammation and the increase in Cp as an acute phase response to irradiation-induced inflammation.
Following the observed radioprotectant and radiorecovery activities of Cu(II)(3,5-DIPS)4 as well as its facilitation of recovery of radiation-induced immuno-ineompetency, the question still remained as to whether or not there was any correlation between these observations and repair or recovery of radiationinduced histopathology. To address this need histopathologieal studies of spleen, bone marrow, thymus, and small intestine were conducted in parallel with immunological studies of animals exposed to LD50/0 irradiation (8. The observed decrease in skin Cu2Zn2SOD following a single ultraviolet irradiation was also reduced by pretreatment with liposomes containing Cu2Zn2SOD [62] . Increased ultraviolet radiation-induced keratinocyte proliferation was also found to be associated with a decrease in total SOD activity which was due mainly to a decrease in Cu2Zn2SOD [63] . Protection against ultraviolet radiation-induced chronic skin damage was also found with topically applied non-steroidal antiinflammatory agents [64] . These agents have been suggested to tbrm Cu chelates in vivo [57] , which may account for their inhibition or repair of ultraviolet radiation induced injury.
Copper(II)2(3,5-DIPS)4 was originally examined for radioproteetant activity based upon reports that Cu2Zn2SOD had radioprotectant activity when given both before and after irradiation. However, subsequent reports suggested that superoxide dispmportionation by Cu2Zn2SOD did not account for its radioprotectant activity. Inactivated polyethylene-glycol derivatized Cu2Zng_SOD was as effective as the enzymatieally active derivative. The very real possibility that these proteins in extracellular spaces are in fact antigenic, although reduced [65] . Adult CF male rots x-irradiated with 15 cGy see "1 day "1 for 7 days followed by 7 days rest for either 3 months or 6 months showed duration related radiation-induced patchy skin hyalinization, which became completely hyalinized during the succeeding 6 months without irradiation [66] . The concentration of Zn in skin of these rats remained normal in both irradiated groups but by the end of yr it had significantly (P < 0.001) decreased to 13 [88] . This factor is an alpha amidated peptide, one of many amide terminus neuronal hormone peptides synthesized by Cu-dependent x-arnidating mixed function oxidases [89] . PAC-AP has more recently been reported to prevent cytokme-induced pancreatic B-cell cytotoxicit3" by inhibiting inducible NOS expression in BTC cells [90] . The [94] . Treatment with 90, 120, or 150 lamol kg l 3 hrs after LDT0/30 irradiation increased survival from 7% for the vehicle-treated mice to 21%, 23%, or 22%, respectively, 200% (P 0.00007), 229% (P 0.000005), or 214% (P 0.00002) increases in survival compared to vehicle-treated mice [94] . Treatment with 150 tmol kg 3 hr before LD10o/30 irradiation (10 Gy, 1.4 Gy minl) and 90, 180, or 360 tmol kg "1 on day 2, 4, and 6 after irradiation produced 28% (P 0.007), 12%, or 16% survival, respectively, versus 0% survival for vehicle-treated mice. Treatment with 120, 240, or 480 lamol Mn-(3,5-DIPS).. kg before LDlf/0 irradiation revealed that only the 240 and 480 lamol kg doses were effective, producing survivals of 16% or 27%, respectively, with no surviving control mice [94] . Treatment with doses of 60, 120, or 240 tmol Mn-(3,5-DIPS) kg after LD0oro irradiation revealed that only the 120 tamol kg dose was efftive, increasing survival 233% above control mice (12% survival) [94] .
Oral treatment with Mn-(3,5-DIPS)2 before or after LD0o/30 irradiation increased survival and recovery of radiation-induced loss of body mass [94] A possible Mn-(3,5-DIPS)2 mechanism of action in overcoming inflammation due to radiation injury is the dovn-regulation of NOS when excess NO is produced as part of the inflammatory response [82] . Alternatively, activation of Mn-dependent guanylyl cyclase [95] , the receptor for NO, by Mn-(3,5-DIPS)z may serve to restore normal physiologic functions involving NO-mediated processes. This understanding is consistent with the suggestion that a ternary NO-Mn-(3,5-DIPS)z complex might form in vivo [82] and have roles in mediating NO function [83] .
The Mn-Desfemoxamine (MnDFO) SOD-mimetic chelate has also been found to be effective in protecting against riboflavin-mediated ultraviolet (365 nm, 2 to 9 J cm"2) phototoxicity [96] . Photohemolysis of erythrocytes was decreased with 500 vl MnDFO. Treatment with 50 or 100 ONI MnDFO did not change 3H-Thymidine incorporation in irradiated (5 J cm"z) GH-U1 human urinary bladder carcinoma cells or irradiated (10 J cm"2) phytohemaglutin-stimulated lymphocytes compared to radiation alone. Higher concentrations of MnDFO were toxic to these cells.
Hahn et al. [97] and Dart et al. [98, 99] [77] [78] [79] . Consequently, the view that Cu or Mn chelates can not be effective SOD-mimetics in preventing Oz-mediated pathology, despite many observations to the contrary is seriously flawed. Finally, Mn chelates will not serve to facilitate the activation of Cu-dependent enzymes nor will Cu chelates facilitate activation of Mn-dependent enzymes.
The SOD-mimetic reactivity of Mn(III)tetrakis-l-methyl-4-pyridylporphyrin pentaehloride [Mn(III)TMPyP] was recently suggested to aount for the restoration of NO-mediated neurotransmission and serves as a lead compound in the development of SOD-mimetics as therapeutic agents for the treatment of neuropathies associated with oxidant stress [100] .
To examine the possibility that treatment with a combination of essential metalloelemem chelates might be effective in increasing survival of lethally irradiated mice, Cu(II)z(3,5-DIPS)4 and Mn-(3,5-DIPS)z were studied using a factorial design [101 ] Irradiation-Induced esophagitis, micro-ulceration, and esophageal stricture as well as cytokine mRNA elevations and squamous cell apoptosis were dramatically decreased in male C3H/HeNsd mice with intraesophageal instillation of mouse MnSOD-plasmid/liposome (SOD2-PL) 24 hr before 35 or 37 Gy local esophageal x-irradiation (58) . Mice bearing orthostatic thoracic tumors treated with mouse SOD2-PL also evidenced esophageal transgenic SOD2 mRNA [102] . These results were suggested to provide support for human SOD2-PL gene therapy in a fractional irradiation paradigm to avoid acute and chronic radiationinduced side effects in a human clinical trial of pulmonary ttunor irradiation 102]. Increased stuwival was also observed at both levels of irradiation. A significant increase in surviving fraction (1.0, P 0.0291) versus 0.5 for control liposome treated mice was observed for 35 Gy irradiated mice treated with 100 tg SOD2-PL/mouse given by the mtra-esophageal route of administration with a significant (P 0.015) decrease in esophagitis in this 30-day study. Mice irradiated with 37 Gy and treated with 200 xg SOD2-PL/mouse or 10 xg SOD2-PL/mouse by intra-esophageal instillation experienced increased surviving fractions of 0.5 (P 0.05) or 0.7 (P 0.0119) respectively compared to non-treated irradiated mice in this 60-day study 102]. While mtra-trachael instillation of transgene before irradiation protected C57BL/6J mice from whole-lung irradiation-induced alveolitis/fibrosis, there was no significant lung protection in SOD2-PL treated SP1-SOD2 or FeVI3/NHsd transgenic mice. Over expression of either human SOD2 or murme Sod2 in the lungs of these transgenic mice did not provide local 11 to 15 Gy irradiated whole-lung or alveolar type II cell protection [103] . Over expression of SOD2 in SP-1 SOD2 mice may have made these mice more sensitive to radiation injury. However, these studies may have been seriously flawed since mice developing pulmonary distress were killed, preventing the possible observation that treated mice might have overcome this radiation-induced inflammatory complication.
Radiation Protection and Recovery with Zinc Chelates.
As pointed out in our earlier review [see 48] treatment with Zn compounds dramatically increased survival of lethally irradiated mice. In the interim it was shown that fractional whole-body /-irradiation of male BALB/C mice given a total doses of 0.5, 1, or 1.5 Gy induced an increase in DNA-protein cross-links in the thymus, spleen, brain, and liver. However, when these mice were given drinking water containing 154 Zn(II)SO4 for 30 days DNA-protein cross-links were dramatically decreased to levels observed in all of these tissues from non-irradiated mice 104].
Fibroblasts cultured in medium containing 100 p_M Zn(II)CI2 had repaired ultraviolet radiationinduced DNA strand-breaks and delayed in apoptotic loss of nucleosomes [105] [54] support the hypothesis that MT synthesis has a role in reducing radiosensitivity. Induction of MT synthesis is a physiological response to oxidant stress as described for IL-1 or endotoxin-mediated responses to this stress as well as other cytokine-mediated responses to radiation injury. [58, 59] .
As pointed out earlier [see 48] Zn(II)(aspartate), is known to have radioprotectant activi:. An important question as to whether or not this compound protected neoplastic cells from radiation inju.w was answered when ip treatment with 90 pmol kg "1 Zn(lI)(aspartate)2 did not inhibit 7-ray radiotherapcutic reduction of tumor volume using three adenocarcinomas of the colon or Ewings sarcoma implanted immunosuppressed mice [107] . Zinc(II)(aspartate). also significantly reduced radiation-induced decrease in hematocrit and thrombocyte, erythrocyte, and leukocyte numbers, an indication of spleen and/or bone man'ow precursor cell sparing effect or rapid recovery of immunocompetence. Zn(II)(aspartate)_ permitted a greater reduction in tumor volume than cysteamine [mercaptoethylamine (MEA)], mET, and WR-2721 and it was as effective as a syngeneie bone marrow transplant [107] . pmol Zn(II)(acetate)2 kg given ip 3 hr before irradiation (3.5 to 7.25 Gy) facilitated post-irradiation recovery of hematocrit, thrombocytes, erythrocytes, and leukocytes in C3H male and female mice [108] . Generally, Zn(II)(aspartate)9., was more effective than the other Zn chelates and administration along with WR-2721 produced a marked synergistic increase in recovery of hematocrit and thrombocytes. Zinc(II)(aspartate)2 was also the only Zn chelate that did not inhibit radiation-induced reduction in growth of adenocarcinomaimplanted and immunosuppressed mice [108] .
Small non-toxic doses of Zn(II)(aspartate)=, 45 pmol kg -1 ip, and WR-2721 175 pmol kg -1 ip, given to female C3H mice 30 min or 10 min before LDl00/30 ,t-irradiation (10.5 Gy, 0.2 Gy min1) produced a synergistic increase in survival of 83% versus 0% for vehicle-treated control mice 109]. Zinc(II)(aspartate), 45 mol kg ip, and WR-2721, 1,400 tmol kg ip, given to female C57BL/6 mice 30 min or 10 min before a fractionated LD00/30 ,-irradiation (5 x 1.9 Gy) also produced a synergistic increase in survival of 83% versus 0% for vehicle-treated control mice. Fraetionated whole body radiation-induced carcinogenesis leading to lymphoid tumors was dramatically decreased from 90, 6 to 9% in C57BL/6 mice treated with Zn(II)(aspartate)2, 45 pmol kglip, and WR-2721, 1,400 nol kg given ip. Thus this combination treatment dramatically decreased radiation-induced lymphoid tumors [108] . A 100 pmol kg " dose of Zn(II)-Desferrioxarnine [Zn-DFO] produced 60% survival in whole body LD50/30 /-irradiated female C3H mice treated 0.5 hr before irradiation while Desferioxamine had no radioproteetant activity [111] . There was no radioprotective effect observed in studies of cultured V79 Chinese hamster cells. However, Zn-DFO concentration dependently prevented radiation-induced plasmid DNA strand-breaks through a concentration range of 0.5 to 2 mM.
Feeding an "antioxidant" diet containing 55 trnol Zn(II)(gluconate)2 kg -day l to C57BL male mice for 45 days before irradiation(6 Gy, 1.8 Gy min") caused an inhibition of TRPM-2, a marker gene for apoptosis expression both before and after irradiation [112] . The bcl-2 mRNA, which is involved in the prevention of apoptosis, and splenocyte number increased steadily after irradiation. The expression of sod-I gene increased and remained elevated for 24 hr, the last time of measurement after irradiation, and synthesis of the eat (catalase) gene increased slightly shortly after irradiation and decreased by 3 hr after irradiation.
Preliminary studies under the same experimental conditions revealed a decrease in frequency of radiationinduced mutations as evidenced by changes in the hypoxanthine-quanine phosphoribosyl-transferase locus of splenocytes from mice fed the antioxidant diet containing Zn(II)(gluconate)2. The maximum antimutagenic effect was detected by the 6 th week of diet administration.
Radioprotectant and Radiorecovery Activity of Calcium-Channel Blockers. New evidence provided by Floersheim and his colleagues document radioprotectant and radiorecovery activities for some Ca-channel blockers [113] [114] [115] [116] . These reports are consistent with the earlier suggestion of Athar et al. [59] that Veraparnil, a Ca-channel blocker, prevents radiation injury-induced conversion of Xanthine Dehydrogenase to Xanthine Oxidase, which synthesizes 02-.
Diltiazem, a benzothiadiazepine Ca-channel blocker, given sc as the hydrochloride salt in distilled water to female mice at doses of 61, 122, or 244 rnol kg " 15 min before LD00/30 (10.5 Gy, 0.15 Gy min"1) irradiation produced 17%, 58%, or 93% survival [113] . A dose of 244 nol kg -1 given sc 10 rain after irradiation produced 42% survival for this radiorecovery paradigm. Nifedipine, a dihydropyridine Ca-channel blocker, given ip at a dose of 4 tmaol kg " in an ethanol vehicle, which provided 50 mmol ethanol kg , 30 min Repair of Radiation Injury before LD00r0 irradiation (8.5 Gy, 0.9 Gy min") produced 100, 4 survival and the vehicle produced 61% survival, a difference of 39, 4 [113] . Treatment with 5 Ixrnol Nimodipin kg", another dihydropyridine Cachannel blocker, produced 82% survival whereas the vehicle containing 43 [58, 59] , this mechanistic feature of Ca-channel blocker activity must be taken into account in examining their potential for radioprotectant activity. It would also be useful to examine this mechanistic aspect of all radiorecovery agents.
Floersheim suggested that Ca-channel blockers might also act by blockade of cell death due to Ca influx into cells following radiation injury [113] . However the antioxidative effects of Ca-eharmel blockers via scavenging of free radicals was suggested as an alternative mechanism of action, which could involve stable essential metalloelement chelate formation following hydrolysis of ester functional groups in vivo. Radical scavenging reactivity of ammothiol radioprotectants and formation of their disulfides was also suggested as a mechanism of their action in overcoming radical-mediated radiation injury [113] . A chelate mechanism for radical scavenging by aminothiols is also plausible. Variations in activity of Ca-eharmel blockers were suggested to be due to variations in bioavailability and receptor-bonding interaction [113] .
Benzothiadiazepines and dihydropyridine Ca-channel blockers may also serve as chelating agents and thus facilitate delivery of essential metalloelements to cells for de novo synthesis of essential metalloelementdependent repair enzymes. Calcium-Channel blockers have also been reported to decrease radiation-induced esophagitis as a consequence of thoracic irradiation. Variation in blood flow was proposed to explain the modified x-ray sensitivity of mouse tumor [113] . Calcium-Channel blocker-induced hypotension and tissue anoxia was negated as the cause of radioprotectant activity of these agents, since other agents causing these conditions had no radioprotecting activity [113] . Subsequently Floersheim (70) . When these mice were treated 30 min before irradiation 59% survived (P < 0.005). Treatment 120 min before irradiation produced only 19% survival (P < 0.05).
Diltiazem given in distilled water to LD0o/0 (10 Gy, 15 cGy mm-) irradiated female BALB/c mice before treatment with 244 lamol kg " ip or sc produced 100% survival (P < 0.005) compared to vehicle-treated mice. The same 244 pmol kg t dose given sc or ip to C57BL6, NMRI, or MAG mice produced significant (P < 0.01 strata-related differences in efficacy: 100%, 67%, or 8% surival respectively [114] .
Nifedipine given 30 min before irradiation at doses of 2.3, 4.5, or 9 ktmol kg t ip to LD00/30 (10.5 Gy, 0.15 Gy min") irradiated female C3H mice produced 0%, 40,4, or 79% (P _< 0.05) sau'vival, respectively, compared to 6% survival for ethanol vehicle-treated control mice [114] . Nitrendipine given at doses of 139 or 278 tmol kg l ip in distilled water to these mice 30 min before irradiation produced significant (P < 0.005) increases of 25% or 29% survival respectively. When they were given 120 min before in'adiation they produced 22% or 30, 6 survival (P 0.01) versus 0,6 survival for distilled water-treated control mice [114] .
Vempamil, given to these mice at doses of 35 [114] .
Combinations of Diltiazem and Nifedipine were also studied using the factorial paradigm. A synergistic increase in survival was found for increasing active doses of Nifedipine and Diltiazem from 61 to 122 prnol kg when given before irradiation [114] [114] . Koch [115] suggested that enhanced local blood flow caused by Ca-channel blockers might be responsible for increased radiosensitivity due to the oxygen effect. The exchange by Koch [115] and Floersheim [116] offered a number of spectflations concerning Ca-channel blockade in radiosensitization and radioproteetion. These related to dose, chemical class, a possible role for small molecular mass solvent molecules, as well as effects on metabolizing enzymes.
Interestingly, calcium was found to be elevated in heart, liver, lung, spleen, and kidney of adult male albino rats but decreased in these tissues of female rats two months after 5 Oy ,t-irradiation [117] . While cardiac Fe was elevated, Fe content decreased in all other tissues of male rats. There were no changes in heart and lung Fe in female rats while liver, spleen, and kidney content decreased in female rats. Zinc was elevated in the heart, decreased in lung and spleen, and unchanged in liver and kidney of both male and female rats [117] .
Radioprotectant Activity of Serotonin and Acyl Melatonin Homologs.
A review of Melatonin, N-acetyl-5-methoxytryptamine, antioxidant effects pointed out that Melatonin is relatively non-toxic and protects against ionizing radiation injury [118] . This review cited the report of Blickenstaff et al. [119] as having shown that Melatonin, the acetylated methoxyether of Serotonin, 5-hydroxytryptarnine, produced 75 % survival in LD00/30 9.5 Gy whole-body irradiated male Swiss ND4 mice. This was an increase in radiation protection compared to Serotonin, which produced only 20 % survival in the same study. Intraperitoneal treatment of these mice with soybean oil solutions or suspensions of 1.1 mmol kg 1 acetyl (Melatonin), propionyl, butanoyl, pentanoyl, hexanoyl, oetanoyl, decanoyl, or hexadecanoyl analogs of 5-methyltryptamine 30 rain before irradiation produced survivals of 0 %, 43 % (P 0.0045), 32 [120] .
Karbownic et al. [121] [122] .
In addition, Blickenstaff et al. [122] reported 95 % survival for 780 larnol kg -1 2-NH2,5-Cl-pyriding and 2-C1,5-NH2-pyridine treated mice, 79 % survival for 2-NH2,5-Br-pyridine treated mice; 5 % survival for 2-NI-I2,4-CH3,6-OH-pyrimidine treated mice, 67 % survival for 5-Cl-l,2,3-benzotriazole treated mice, 20 % survival for 2,6-diNH2-9,10-anthraqttinone treated mice, 14% survival for 1-NH2,4-Cl-napthalene treated mice, and quite interestingly, 0 % survival for 4-Cl-acetylaniline treated mice even though the non-acetylated compound produced 68 % survival.
These substituted anilines represent an interesting class of radioprotectants. Their potential for influencing essential metalloelement metabolism in facilitating repair of radiation injury remains to be explained. Amino group sulfation or glucuronide formation offer potential pathways for the formation of ligands capable of acting as chelating agents in facilitating tissue distribution of essential metalloelements needed for de novo syntheses of essential metalloelement dependent enzymes required for repair of radiation injury.
Radioprotectant Activity of Curcumin.
Curcumin, a I-diketone {1,7-bis(4'-hydroxy-3'-methoxyphenyl)-l,6-heptadiene-3,5-dione}, is a yellow major component of Turmeric, a spice prepared from dried rhizomes of Curcuma longa L. Tumeric is widely used to season foods in Asian countries and in particular, Indian Ctna3,. It is of particular interest to note that Curcuma longa L is a fungus and fungi are well known for their high copper content. Since 13-diketones are well known chelating agents [123, 124] and this fully conjugated [5- [126] reported that feeding Curcumin decreased the incidence of marnmm3' tumor m rats. A 1% Curcumin diet fed to 2.6 Gy whole-body irradiated pregnant Wistar-MS rats just prior to pup birth (a mammary tumor imtiating procedure) and then implanted with diethylstilbestrol sustained release pellets for 12 mo following weaning (a mammary tumor promoter regimen) caused a dramatically decreased incidence of mammary tumor. Tumor formation decreased from 84.6 % for the control diet led group versus a 28 % incidence for the Curcumin fed rats. Feeding the diet containing Curcumin significantly (P<0.001) reduced the number of rats with tumors and the number of tumors per rat and increased the latency period for mammary tumor formation (P< 01001). Using this same pregnant Wistar-MS rat model of marnmm" tumorogenesis and feeding a 1% Curcumin diet for a brief period from day-11 of pregnancy to day-23, the day of birth, with 1.5 Gy whole-body irradiation on day-20, prior to birth of the rat pups, again significantly (P<0.0001) decreased the number of dams with mammary tumors from 19 (70.3 % incidence) for the control group to 5 (18.5 % incidence) for the Cureumin fed rats. This Curcumin diet protocol also significantly (P<0.0001) delayed development of mammary tumors in Curcumin fed rats. Eventually mammary tumors did develop during the last two months of this 12-mo study [127] . Curcumin was fed for only 10 days in this study while it was fed for yr in the first study (82) . Thus 
